FGFR4 and neoplasm: This mechanism has been validated in hepatocellular carcinoma models, where sustained activation of the FGFR4–MAPK pathway induced EMT, mediated immune evasion and metastasis, and enhanced tumor invasiveness (Xie et al., 2023).